587 related articles for article (PubMed ID: 22521499)
1. Modulation of pyramidal cell output in the medial prefrontal cortex by mGluR5 interacting with CB1.
Kiritoshi T; Sun H; Ren W; Stauffer SR; Lindsley CW; Conn PJ; Neugebauer V
Neuropharmacology; 2013 Mar; 66():170-8. PubMed ID: 22521499
[TBL] [Abstract][Full Text] [Related]
2. Rescue of Impaired mGluR5-Driven Endocannabinoid Signaling Restores Prefrontal Cortical Output to Inhibit Pain in Arthritic Rats.
Kiritoshi T; Ji G; Neugebauer V
J Neurosci; 2016 Jan; 36(3):837-50. PubMed ID: 26791214
[TBL] [Abstract][Full Text] [Related]
3. Group II mGluRs modulate baseline and arthritis pain-related synaptic transmission in the rat medial prefrontal cortex.
Kiritoshi T; Neugebauer V
Neuropharmacology; 2015 Aug; 95():388-94. PubMed ID: 25912637
[TBL] [Abstract][Full Text] [Related]
4. mGluR1, but not mGluR5, activates feed-forward inhibition in the medial prefrontal cortex to impair decision making.
Sun H; Neugebauer V
J Neurophysiol; 2011 Aug; 106(2):960-73. PubMed ID: 21613584
[TBL] [Abstract][Full Text] [Related]
5. CB1 augments mGluR5 function in medial prefrontal cortical neurons to inhibit amygdala hyperactivity in an arthritis pain model.
Ji G; Neugebauer V
Eur J Neurosci; 2014 Feb; 39(3):455-66. PubMed ID: 24494685
[TBL] [Abstract][Full Text] [Related]
6. Modulation of neuronal microcircuit activities within the medial prefrontal cortex by mGluR5 positive allosteric modulator.
Pollard M; Bartolome JM; Conn PJ; Steckler T; Shaban H
J Psychopharmacol; 2014 Oct; 28(10):935-46. PubMed ID: 25031220
[TBL] [Abstract][Full Text] [Related]
7. Cell type-specific regulation of inhibition via cannabinoid type 1 receptors in rat neocortex.
De-May CL; Ali AB
J Neurophysiol; 2013 Jan; 109(1):216-24. PubMed ID: 23054605
[TBL] [Abstract][Full Text] [Related]
8. Activation of metabotropic glutamate 5 (mGlu5) receptors induces spontaneous excitatory synaptic currents in layer V pyramidal cells of the rat prefrontal cortex.
Marek GJ; Zhang C
Neurosci Lett; 2008 Sep; 442(3):239-43. PubMed ID: 18621097
[TBL] [Abstract][Full Text] [Related]
9. Endocannabinoid- and mGluR5-dependent short-term synaptic depression in an isolated neuron/bouton preparation from the hippocampal CA1 region.
Sheinin A; Talani G; Davis MI; Lovinger DM
J Neurophysiol; 2008 Aug; 100(2):1041-52. PubMed ID: 18497350
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological evidence of functional inhibitory metabotrophic glutamate receptors on mouse arousal-related cholinergic laterodorsal tegmental neurons.
Kohlmeier KA; Christensen MH; Kristensen MP; Kristiansen U
Neuropharmacology; 2013 Mar; 66():99-113. PubMed ID: 22381584
[TBL] [Abstract][Full Text] [Related]
11. Role of metabotropic glutamate receptor 1 in the basolateral amygdala-driven prefrontal cortical deactivation in inflammatory pain in the rat.
Luongo L; de Novellis V; Gatta L; Palazzo E; Vita D; Guida F; Giordano C; Siniscalco D; Marabese I; De Chiaro M; Boccella S; Rossi F; Maione S
Neuropharmacology; 2013 Mar; 66():317-29. PubMed ID: 22796105
[TBL] [Abstract][Full Text] [Related]
12. Pain-related increase of excitatory transmission and decrease of inhibitory transmission in the central nucleus of the amygdala are mediated by mGluR1.
Ren W; Neugebauer V
Mol Pain; 2010 Dec; 6():93. PubMed ID: 21162731
[TBL] [Abstract][Full Text] [Related]
13. Examination of a role for metabotropic glutamate receptor 5 in the medial prefrontal cortex in cocaine sensitization in rats.
Timmer KM; Steketee JD
Psychopharmacology (Berl); 2012 May; 221(1):91-100. PubMed ID: 22147256
[TBL] [Abstract][Full Text] [Related]
14. NMDA receptors, mGluR5, and endocannabinoids are involved in a cascade leading to hippocampal long-term depression.
Izumi Y; Zorumski CF
Neuropsychopharmacology; 2012 Feb; 37(3):609-17. PubMed ID: 21993209
[TBL] [Abstract][Full Text] [Related]
15. Metabotropic glutamate receptors 1 and 5 differentially regulate CA1 pyramidal cell function.
Mannaioni G; Marino MJ; Valenti O; Traynelis SF; Conn PJ
J Neurosci; 2001 Aug; 21(16):5925-34. PubMed ID: 11487615
[TBL] [Abstract][Full Text] [Related]
16. The synthetic cannabinoid 5F-AMB changes the balance between excitation and inhibition of layer V pyramidal neurons in the mouse medial prefrontal cortex.
Domoto M; Sasase H; Wada S; Ito S; Deyama S; Hinoi E; Kaneko S; Kaneda K
Psychopharmacology (Berl); 2018 Aug; 235(8):2367-2376. PubMed ID: 29858613
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors.
Lea PM; Movsesyan VA; Faden AI
Br J Pharmacol; 2005 Jun; 145(4):527-34. PubMed ID: 15821750
[TBL] [Abstract][Full Text] [Related]
18. Dual modulation of excitatory synaptic transmission by agonists at group I metabotropic glutamate receptors in the rat spinal dorsal horn.
Zhong J; Gerber G; Kojić L; Randić M
Brain Res; 2000 Dec; 887(2):359-77. PubMed ID: 11134626
[TBL] [Abstract][Full Text] [Related]
19. Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-D-aspartate responses in medium spiny striatal neurons.
Pisani A; Gubellini P; Bonsi P; Conquet F; Picconi B; Centonze D; Bernardi G; Calabresi P
Neuroscience; 2001; 106(3):579-87. PubMed ID: 11591458
[TBL] [Abstract][Full Text] [Related]
20. Activation of group I mGluRs increases spontaneous IPSC frequency in rat frontal cortex.
Chu Z; Hablitz JJ
J Neurophysiol; 1998 Aug; 80(2):621-7. PubMed ID: 9705455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]